# Theranova Dialyzer and Chronic Kidney Disease - Mineral Bone Disorder (CKD-MBD)

> **NCT03169400** · — · UNKNOWN · sponsor: **University of Milan** · enrollment: 20 (estimated)

## Conditions studied

- End Stage Renal Failure on Dialysis
- Vascular Calcification
- Oxidative Stress

## Interventions

- **DEVICE:** Theranova dialyzer

## Key facts

- **NCT ID:** NCT03169400
- **Lead sponsor:** University of Milan
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-10-01
- **Primary completion:** 2018-08-31
- **Final completion:** 2018-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2017-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03169400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03169400, "Theranova Dialyzer and Chronic Kidney Disease - Mineral Bone Disorder (CKD-MBD)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03169400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*